Close Menu

NEW YORK (GenomeWeb) – Indian consumer genomics company Mapmygenome is partnering with blockchain genetics startup Digital DNAtix to provide extra security and privacy for its direct-to-consumer genetic tests. The blockchain technology also will allow researchers to access anonymous data for their work, the companies said.

Digital DNAtix, of Ramat Gan, Israel, will provide Mapmygenome with a platform to offer its genome testing, analysis, and related personalized medicine services in a faster, more secure environment than previously available.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.